{
    "data": [
        {
            "id": "4474619",
            "type": "article",
            "attributes": {
                "publishOn": "2021-12-10T15:12:33-05:00",
                "isLockedPro": false,
                "commentCount": 144,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1300036753/image_1300036753.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris Stock: A Potential Cash Cow At An Attractive Entry Point",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106173",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "352589",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/4474619-viatris-stock-a-potential-cash-cow-at-an-attractive-entry-point"
            }
        },
        {
            "id": "4474595",
            "type": "article",
            "attributes": {
                "publishOn": "2021-12-10T13:14:16-05:00",
                "isLockedPro": false,
                "commentCount": 49,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1300036753/image_1300036753.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris Is A Strong Buy",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "80836",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "352550",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4474595-viatris-strong-buy-undervalued"
            }
        },
        {
            "id": "4468958",
            "type": "article",
            "attributes": {
                "publishOn": "2021-11-12T14:24:37-05:00",
                "isLockedPro": false,
                "commentCount": 480,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1317916302/image_1317916302.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris Is A Compelling Deep Value Pick",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104751",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "348869",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4468958-viatris-is-a-compelling-deep-value-pick"
            }
        },
        {
            "id": "4466945",
            "type": "article",
            "attributes": {
                "publishOn": "2021-11-08T11:12:36-05:00",
                "isLockedPro": false,
                "commentCount": 69,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/871263272/image_871263272.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: A Look At Whether Q3 Sales Can Tilt The Scales",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103219",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "348325",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4466945-viatris-whether-q3-sales-can-tilt-the-scales"
            }
        },
        {
            "id": "4460729",
            "type": "article",
            "attributes": {
                "publishOn": "2021-10-20T07:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 142,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1157225206/image_1157225206.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: Close To Bottoming Out",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105995",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "345637",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4460729-viatris-stock-close-to-bottoming-out"
            }
        },
        {
            "id": "4458270",
            "type": "article",
            "attributes": {
                "publishOn": "2021-10-04T07:45:00-04:00",
                "isLockedPro": false,
                "commentCount": 193,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157308559/image_157308559.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "3 Reasons Viatris Is The Ultimate High-Yield Buffett-Style 'Fat Pitch'",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "101900",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "343550",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4458270-3-reasons-viatris-is-the-ultimate-high-yield-buffett-style-fat-pitch"
            }
        },
        {
            "id": "4455487",
            "type": "article",
            "attributes": {
                "publishOn": "2021-09-16T00:22:33-04:00",
                "isLockedPro": false,
                "commentCount": 101,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1253014020/image_1253014020.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: Still A Strong Buy Despite Stagnant Share Price",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "341552",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4455487-viatris-stock-vtrs-earnings-strong-buy-stagnant-share-price"
            }
        },
        {
            "id": "4453119",
            "type": "article",
            "attributes": {
                "publishOn": "2021-09-02T01:13:17-04:00",
                "isLockedPro": false,
                "commentCount": 88,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1217026295/image_1217026295.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: This May Be The Perfect Time To Buy",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105703",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "339954",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4453119-viatris-this-may-be-the-perfect-time-to-buy"
            }
        },
        {
            "id": "4453096",
            "type": "article",
            "attributes": {
                "publishOn": "2021-09-01T22:33:49-04:00",
                "isLockedPro": false,
                "commentCount": 26,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/452153266/image_452153266.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Why Viatris Is Growth At A Reasonable Price",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "22786",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "339916",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4453096-viatris-earnings-stock-growth-at-a-reasonable-price"
            }
        },
        {
            "id": "4447159",
            "type": "article",
            "attributes": {
                "publishOn": "2021-08-09T10:15:00-04:00",
                "isLockedPro": false,
                "commentCount": 73,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/178527679/image_178527679.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: What Lies Ahead After Q2-2021",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103219",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "336670",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4447159-viatris-what-lies-ahead-after-q2-results"
            }
        },
        {
            "id": "4441669",
            "type": "article",
            "attributes": {
                "publishOn": "2021-07-27T12:23:48-04:00",
                "isLockedPro": false,
                "commentCount": 93,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1064725516/image_1064725516.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "The Real Value Of Viatris Stock",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106149",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "334755",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4441669-the-real-value-of-viatris-stock"
            }
        },
        {
            "id": "4437314",
            "type": "article",
            "attributes": {
                "publishOn": "2021-06-30T16:03:26-04:00",
                "isLockedPro": false,
                "commentCount": 120,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1248493102/image_1248493102.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: Buy Signals Are So Strong It's Hard To Ignore",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "331515",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4437314-viatris-buy-signals-are-so-strong-its-hard-to-ignore"
            }
        },
        {
            "id": "4432099",
            "type": "article",
            "attributes": {
                "publishOn": "2021-05-30T06:04:34-04:00",
                "isLockedPro": false,
                "commentCount": 53,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1250581414/image_1250581414.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris Is A Dirt Cheap Buy, But May Not Be For Everyone",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105703",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "327383",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4432099-viatris-dirt-cheap-buy-not-for-everyone"
            }
        },
        {
            "id": "4431075",
            "type": "article",
            "attributes": {
                "publishOn": "2021-05-25T06:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 70,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/952251212/image_952251212.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: Good News, Bad News",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103219",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "326691",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4431075-viatris-good-news-bad-news"
            }
        },
        {
            "id": "4418732",
            "type": "article",
            "attributes": {
                "publishOn": "2021-04-12T17:46:11-04:00",
                "isLockedPro": false,
                "commentCount": 101,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/482749643/image_482749643.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: It's Going To Get Worse Before It Gets Better",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106055",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "319241",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4418732-viatris-stock-going-to-get-worse-before-it-gets-better"
            }
        },
        {
            "id": "4418604",
            "type": "article",
            "attributes": {
                "publishOn": "2021-04-12T06:12:23-04:00",
                "isLockedPro": false,
                "commentCount": 110,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/862433964/image_862433964.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris: The Bubble And Its Hangover",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103219",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "320823",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4418604-viatris-bubble-hangover"
            }
        },
        {
            "id": "4407924",
            "type": "article",
            "attributes": {
                "publishOn": "2021-02-22T12:38:34-05:00",
                "isLockedPro": false,
                "commentCount": 68,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Viatris' Guidance Blames Forecasts On Short-Term Forces, But Still Low-Balls The Dividend",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105192",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "314444",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4407924-viatris-guidance-blames-forecasts-on-short-term-forces-still-low-balls-dividend"
            }
        },
        {
            "id": "4398279",
            "type": "article",
            "attributes": {
                "publishOn": "2021-01-11T12:54:36-05:00",
                "isLockedPro": false,
                "commentCount": 67,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Investors Should Keep Their Shares In Viatris And Consider Buying More",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "80836",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "308432",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "606785",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4398279-investors-should-keep-shares-in-viatris-and-consider-buying"
            }
        }
    ]
}